Clinical Utility of Emergency Capsule Endoscopy for Diagnosing the Source and Nature of Ongoing Overt Obscure Gastrointestinal Bleeding
Table 1
Patient and lesion characteristics at the time of capsule endoscopy for identifying the source of ongoing overt obscure gastrointestinal bleeding.
Variables
Group
value
A, , CE at ≤48 h
B, , CE at >48 h
Sex
Male
10 (67)
65 (58)
0.5189
Female
5 (37)
47 (42)
Age category
<65 years
3 (20)
45 (46)
0.0837
≥65 years
12 (80)
67 (54)
Concomitant disease
Cardiovascular disease
3 (20)
9 (10)
0.0650
Chronic renal failure
1 (7)
4 (7)
Chronic liver disease
0 (0)
2 (2)
Cerebrovascular disease
1 (7)
1 (2)
Medication
Antiplatelet drugs
2 (13)
15 (13)
0.9949
NSAIDs
0 (0)
11 (10)
0.0871
Hb level (g/dL)
9.2
7.1
0.7049
Transfusion
3 (20)
30 (29)
0.5736
Lesion type
12 (80)
53 (47)
0.0174
Vascular lesion
5 (33)
24 (21)
0.3023
Ulcerative lesion
2 (13)
20 (18)
0.6637
Neoplastic lesion
4 (27)
8 (7)
0.0356
Meckel’s diverticulum
1 (7)
1 (1)
0.1801
The patients were stratified according to the timing of CE relative to the onset of bleeding. Data are shown as frequency (percentage) or mean, as appropriate. Abbreviations: CE, capsule endoscopy; Hb, hemoglobin; NSAID, nonsteroidal anti-inflammatory drug.
